Chief Operating Officer Kelly Paul Edward bought $86,060 worth of shares (200,000 units at $0.43), increasing direct ownership by 94% to 412,295 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RLMD· Relmada Therapeutics Inc.

Health Care

Original source

Chief Operating Officer Kelly Paul Edward bought $86,060 worth of shares (200,000 units at $0.43), increasing direct ownership by 94% to 412,295 units (SEC Form 4) | Quantisnow